NEO · Company research
NeoGenomics, Inc. (NEO): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 15.97 | $2,523,729,990 | 2378190990.00 | 964.5000000000000000 | — | — | 12.5150255385408815 | 3.2119475724547301 | 214.96848296422487222812 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.